As counting ends in the 243-seat election, Nitish Kumar’s promises collide with poverty, caste realities, and a ₹38,278 ...

(Nasdaq: MGX) (the "Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create ...

Booster Therapeutics is developing a novel therapeutic approach that aims to combat the accumulation of deviant proteins in cells, which are a major driver of Parkinson's and other complex diseases ...

IMPD celebrates the graduation of its 27th leadership development class, emphasizing the program's role in fostering ...

As we are in what I like to call the seventh-inning stretch of the fall semester, my English composition students are preparing to ...

Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...

Research increasingly shows that exposure to fine particulate matter, or PM2.5, microscopic pollutants small enough to enter ...

Parkinson’s disease steals ease and movement by striking a narrow band of midbrain neurons. If you study or cover neuroscience, you have seen the promise and frustration in efforts to grow these ...

Three research scientist entrepreneurs with roots in university labs and life sciences startup companies have announced ...

In 2023, U.S. Surgeon General Vivek Murthy called loneliness and isolation a public health epidemic. His advisory linked ...

Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for suprachoroidal delivery. CoTx-101 represents a potential b ...

Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in ...